This calculator estimates your risk of developing opioid-induced hyperalgesia based on key medical factors. Opioid-induced hyperalgesia is a condition where pain becomes more severe with increased opioid use.
It sounds impossible: you’re taking more opioids to control your pain, but it’s getting worse. Not just a little - a lot. The pain spreads. Light touches hurt. Your original injury or condition hasn’t changed, yet your body seems to be screaming louder than ever. This isn’t a mistake. It’s not weakness. It’s opioid-induced hyperalgesia - a real, measurable, and often misunderstood side effect of long-term opioid use.
First noticed in rats back in 1971, OIH has since been confirmed in humans. Studies show that people on high-dose morphine, hydromorphone, or fentanyl - especially those with kidney problems - are most at risk. The pain doesn’t stay put. It spreads beyond the original injury site. A lower back pain might suddenly involve the hips, thighs, and even the feet. That’s a red flag.
Tolerance means your body adapts to the opioid’s pain-relieving effect. You need a higher dose to get the same relief. But your pain level stays about the same - it doesn’t get worse.
OIH means your pain is actually intensifying. You take more opioids, and your pain gets worse. You might start feeling pain in places you never had it before. You might react painfully to things that never hurt before - like a bandage, a hug, or even a gentle touch.
One key sign of OIH is allodynia: pain from something that shouldn’t hurt. Cotton swabs, bed sheets, or a light breeze can trigger sharp, burning, or shooting pain. This is a hallmark of central nervous system sensitization - the same process seen in nerve damage and chronic neuropathic pain.
The main culprit is the NMDA receptor. Opioids bind to their target receptors, but in doing so, they accidentally trigger a chain reaction that turns on NMDA receptors in your spinal cord. These receptors are like amplifiers for pain signals. Once they’re activated, they crank up the volume on everything your nerves send to your brain.
That triggers more release of glutamate - a key pain-signaling chemical - and less reuptake of it. Your brain and spinal cord get flooded. Pain pathways get rewired. Your pain threshold drops. Your tolerance for discomfort vanishes.
Other factors include:
This isn’t just theory. Animal studies show clear increases in pain sensitivity after morphine, heroin, and fentanyl exposure. Human studies using sensory testing confirm lower pain thresholds in patients on long-term opioids - even in areas far from their original injury.
Studies estimate OIH affects between 2% and 10% of people on long-term opioid therapy. But because it’s often misdiagnosed, the real number could be higher. Many patients are told they just need more medication - when what they really need is a different approach.
Doctors look for:
It’s a process of elimination. Your doctor must rule out:
Some clinics use quantitative sensory testing - applying controlled heat, pressure, or touch to measure pain thresholds. If your pain threshold has dropped significantly in areas unrelated to your original condition, that’s strong evidence for OIH.
But here’s the hard truth: Only about 35% of pain specialists feel confident diagnosing OIH. Many cases go unnoticed - or worse, misdiagnosed as addiction or non-compliance.
1. Reduce the opioid dose
This sounds backwards. If you’re in more pain, why take less? But because OIH is caused by the opioid itself, lowering the dose can actually reduce the pain. Think of it like turning down a volume knob that’s been cranked too high. Studies show patients often report less pain after a slow, controlled taper - even if they’re on less medication.
2. Switch opioids - try methadone
Methadone is unique. It works on opioid receptors like other opioids, but it also blocks NMDA receptors - the very ones driving OIH. That’s why switching to methadone often works better than just increasing the dose of morphine or oxycodone. One study showed patients who switched to methadone needed 40% less pain medication after surgery.
3. Add NMDA blockers
Drugs like ketamine (given in low doses) and magnesium sulfate can calm overactive NMDA receptors. These aren’t first-line treatments, but they’re powerful tools when OIH is confirmed. Ketamine infusions, for example, have helped patients who didn’t respond to anything else.
4. Use gabapentin or pregabalin
These drugs target calcium channels in nerves, which helps reduce the over-firing that happens in central sensitization. They’re commonly used for nerve pain - and they work well for OIH too. Typical doses range from 900-3600 mg/day for gabapentin, or 150-600 mg/day for pregabalin.
5. Non-drug approaches
Physical therapy, graded movement, and cognitive behavioral therapy (CBT) help retrain your nervous system. They don’t cure OIH, but they help you rebuild tolerance to movement and touch. Many patients find that combining medication changes with therapy gives the best results.
But the evidence is growing. Animal models are clear. Human sensory tests are consistent. And the clinical pattern - worsening pain with higher doses, spreading pain, allodynia - is too consistent to ignore.
Ignoring OIH leads to dangerous cycles: more drugs → more pain → more drugs. Patients end up on extremely high doses, with no relief. Some develop dependence, withdrawal symptoms, or even overdose.
Recognizing OIH changes everything. It shifts the goal from “more opioids” to “reset the nervous system.” It means stopping the harm, not just managing symptoms.
Don’t stop opioids cold turkey. That can trigger severe withdrawal. But don’t keep increasing the dose hoping it will help. That’s the trap.
Work with a pain specialist familiar with OIH. This isn’t something most general practitioners are trained to handle. You need someone who understands the neurobiology - not just the prescription pad.
There’s hope. OIH is reversible. Pain can improve. Sensitivity can decrease. But only if the right steps are taken - and early.
Yes, though it’s more common after several months. In some cases, especially with high-dose intravenous opioids or in people with kidney problems, OIH can develop within 2-4 weeks. It’s not just a long-term problem - it can show up faster than most expect.
No. Addiction involves compulsive drug use despite harm, cravings, and loss of control. OIH is a biological change in how your nervous system processes pain. You can have OIH without being addicted, and you can be addicted without having OIH. But the two can happen together, which makes treatment more complex.
Sometimes, but only under strict control. Switching to methadone or adding NMDA blockers like ketamine may allow you to stay on lower opioid doses safely. In many cases, reducing or eliminating opioids leads to better pain control. The goal isn’t necessarily to stop opioids forever - it’s to stop the cycle that’s making your pain worse.
No. Most people on opioids don’t develop it. But it’s not rare - studies suggest 2-10% of long-term users are affected. Risk goes up with higher doses, longer use, kidney issues, and certain genetic factors. If you’re on high-dose opioids for chronic pain, it’s worth asking about.
Recovery varies. Some patients notice improvement within days of reducing their dose. Others take weeks or months, especially if the nervous system has been sensitized for over a year. Combining dose reduction with gabapentin, physical therapy, and CBT can speed up recovery. Patience and consistency matter more than speed.
Yes. Researchers are testing new NMDA receptor modulators and kappa-opioid receptor agonists that provide pain relief without triggering hyperalgesia. Some are exploring gene-based therapies to identify people at higher risk before they start opioids. While these are still in trials, they represent the next step in safer pain management.